175 results
10-K
2021 FY
EX-10.25
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
10-K
2021 FY
EX-10.31
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
10-K
2021 FY
EX-10.33
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
10-K
2021 FY
EX-10.34
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
10-K
2021 FY
EX-10.32
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
8-K
EX-10.6
kg1ddfl7
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.2
4gw5w8beu5j8 uhcav
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.4
i97rdnm652
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.5
hrzkg8e3j hhc
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.3
a0f8ijt
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.1
vueehx8o
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.7
rw6c1j
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.1
6ndt9z
16 Feb 21
Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
4:51pm
8-K
EX-10.2
z1h8upo
16 Feb 21
Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
4:51pm
S-4/A
EX-10.48
k28abfa
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
S-4/A
EX-10.44
w90e1sp9rp08j1a
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
S-4/A
EX-10.43
73w2 ddq3m1qk0i0mdt
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
S-4/A
EX-10.46
a03px4hqdreyvs
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am